tripelennamine

For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.

Do not use in horses intended for food purposes. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Tripelennamine Hydrochloride Injection

For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.

Treated cattle must not be slaughtered for food during treatment and for 4 days following the last treatment. Milk that has been taken during treatment and for 24 hours (2 milkings) after the last treatment must not be used for food. A withdrawal time has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Tripelennamine Hydrochloride Injection

For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.

RE-COVR™

For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.

RE-COVR™

For use in horses and cattle in conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. See package onsert for complete indications for use.

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine

Administration of tripelennamine hydrochloride may give rise to excitement, ataxia, and convulsions. Central nervous system stimulation in the form of hyperexcitability, nervousness, and muscle tremors lasting up to 20 minutes have been noted in horses following administration. Depression of the central nervous system and incoordination may occur when the drug is used at therapeutic dose levels. Disturbances in gastrointestinal function may occur in some instances.

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine

Cattle: Milk taken during treatment and for 24 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 4 days following the last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves.

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine

Not for use in humans. Keep out of reach of children. To obtain a Safety Data Sheet, contact KineticVet at 1-877-786-9882 or www.KineticVet.com.

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine

Horses - Do not use in horses intended for human consumption.

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine

Administer intramuscularly at a dose of 0.5 milligram per pound of body weight.

Intramuscular, Intravenous

Do not use in horses intended for food purposes. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Tripelennamine Hydrochloride Injection

For intramuscular use only at a dose of 0.5 milligram per pound of body weight.

Intravenous, Intramuscular

RE-COVR™

Administer intravenously or intramuscularly at a dose of 0.5 milligram per pound of body weight.

Intramuscular, Intravenous

Treated cattle must not be slaughtered for food during treatment and for 4 days following the last treatment. Milk that has been taken during treatment and for 24 hours (2 milkings) after the last treatment must not be used for food. A withdrawal time has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Tripelennamine Hydrochloride Injection

For intramuscular use only at a dose of 0.5 milligram per pound of body weight.

Intravenous, Intramuscular

RE-COVR™

For intramuscular use only at a dose of 0.5 milligram per pound of body weight.

Intravenous, Intramuscular

RE-COVR™

Horses: Administer intramuscularly only at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight). This dose may be repeated in 6-12 hours if necessary. Cattle: Administer intravenously or intramuscularly at a dose of 0.5 mg per lb of body weight (2.5 mL for each 100 lbs of body weight). This dose may be repeated in 6-12 hours if necessary. The intravenous route of administration may provide a more rapid onset of action. Use aseptic technique to administer RE-COVR™ (tripelennamine hydrochloride injection). Warm the solution to near body temperature prior to administration. Intramuscular injection should be made into the heavy musculature of the hind leg or cervical area. While venomous snake bites have been treated with antihistaminic drugs, other conjunctive therapy is required because of toxic reactions associated with the protein complex of venom. Do not puncture the stopper more than 30 times, use within the 24-month product expiry.

INTRAMUSCULAR, INTRAVENOUS

RE-COVR™ (tripelennamine hydrochloride injection) 20 mg per mL Antihistamine